Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Physicians Committee for Responsible Medicine

T. J. Key

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

Robert Busch

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

University of Colorado Department of Medicine

R. Johnson

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Cardiology Fiesta 2017

R. DeFronzo

State-of-the-Art, Treatment of Diabetic Kidney Disease (DKD)

Primary Care Education Consortium

S. Brunton

Is Obesity Management the Next Frontier?

Canadian Collaborative Research Network

A. Michael Lincoff

Current Status of Prevention and Treatment of Diabetic Nephropathy

George Bakris

Patients in Cardiometabolic Jeopardy: Evolving Strategies for Cardio…

MUSC Cardiology

D. Lloyd-Jones

Use of Finerenone in Patients with Diabetes Who Have Kidney Disease

The Texas Heart Institute

G. Bakris

What's the Ideal Therapy for Obesity?

Stanford Medicine

A. Yeoh

ACC 2024 Insights: Evolving Pharmacology for HFrEF vs. HFpFF - With …

ACC 2024 Insights

M. Costanzo

SGLT2 Inhibitors and Heart Failure in Type-2 Diabetes Mellitus

Javed Butler

Diabetes and Heart Failure: The New Frontier

Mount Sinai Advanced Innovations in Heart Failure Symposium 2019

E. Braunwald

Management of Kidney Health in CKD and DKD: A Cased-Based Multiple-c…

Bijin Thajudeen

Updates in Nephrology

University of Colorado Department of Medicine

A. Jovanovich

Highlights From the 81st ADA Scientific Sessions: The AMPLITUDE Study

Richard Pratley

Pre-Operative Medical Evaluation Update

Scripps Health

J. Diamant

Diabetes Management in CKD: KDIGO 2022 Clinical Practice Update

Cleveland Clinic Endocrinology & Metabolism Institute

L. Caramori

ADA 2022: Heart Failure Hospitalization Among Non-Hispanic Black Com…

Basem Mishriky

Heart Failure, the Picture is Changing: Q&A Discussion

Heart, Diabetes and Kidney: Make the Link

P. Seferovic, E. Standl, M. Ibrahim